Sponsor
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
 — 
See All Episodes
Subscribe

Hey, LA listener!

Download our app for the optimal streaming experience

Apple Store logo Google play logo
  • Listen Now Playing Listen
AirTalk

COVID-19 AMA: J&J Says Its Vaccine Is Effective Against Delta Variant, WHO Says All Authorized Vaccines Should Be Recognized By The West And More

By AirTalk Staff
Published Jul 2, 2021
TIJUANA, MEXICO - JUNE 17: Detail of boxes with the U.S. donated Johnson & Johnson vaccine against Covid-19 at Universidad de Baja California on June 17, 2021 in Tijuana, Baja California. After the visit of Vice president Harris to Mexico, US sent a donation of 1.35 million doses of Johnson and Johnson vaccine. Vaccines will be administrated to anyone over 18 in 39 towns from the Mexican side of the border with United States. The aim of the project is to boost vaccination rates to level of the American cities across the border. (Photo by Francisco Vega/Getty Images)
Detail of boxes with the U.S. donated Johnson & Johnson vaccine against Covid-19 at Universidad de Baja California on June 17, 2021 in Tijuana, Baja California.
(
Francisco Vega/Getty Images
)
Listen 17:18
COVID-19 AMA J&J Says Its Vaccine Is Effective Against Delta Variant, WHO Says All Authorized Vaccines Should Be Recognized By The West And More

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Annabelle De St. Maurice from University of California Los Angeles/Mattel Children’s hospital.

Topics today include:

  • J&J says its vaccine is effective against Delta variant

  • WHO says all vaccines it authorized should be recognized by reopening countries

  • White House says it will miss July 4 vaccination goal

  • Postpartum depression on the rise during the pandemic

  • Experts believe Novavax may play a role in combating vaccine hesitancy

  • Delta variant is not driving a surge in hospitalization rates in England

Guest: 

Annabelle De St. Maurice, M.D., assistant professor of pediatrics in the division of infectious diseases and the co-chief infection prevention officer at University of California Los Angeles/Mattel Children’s hospital; she tweets